Similar to the mechanism we reported previously for the SPTLC1 ALS variants,5 we predict that this overproduction of sphingolipids in the E260K SPTLC2 variant is secondary to an impaired inhibitory effect of ORMDLs on the SPT complex. This evidence concerns the gene SPTLC2 and amyotrophic lateral sclerosis.